Trial intelligence / Profile preview

Sumatriptan in 5-ISMN Induced Headache Model

NCT02485340Completed

Sponsor
Dansk Hovedpinecenter
Start
Apr 2015
Primary completion
Aug 2015
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial in migraine comparing Sumatriptan with Placebo (2 arms). Primary endpoints: Median headache score 0 hours after sumatriptan/placebo and Median headache score 2 hours after sumatriptan/placebo. Started Apr 2015; status: completed.

02

Drugs

sumatriptan
03

Conditions

migraine

Beyond the preview

Go deeper on NCT02485340.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02485340.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call